Loading...
Loading...
Among the 2 tracked institutional investors we monitor, CLDI (CALIDI BIOTHERAPEUTICS INC) is held with a combined value of $40.69K across 34,983 shares. The largest holder is VANGUARD GROUP INC with a position worth $40.63K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$40.69K
Total Shares Held
34,983
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $40.63K | 0.00% | New |
| 2 | FMR LLC | $61 | 0.00% | -98.8% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CLDI with a position worth $40.63K, representing 0.00% of their portfolio. In total, 2 institutional investors hold CLDI with a combined value of $40.69K.
In the most recent quarter, 1 fund opened a new position in CLDI. Additionally, 1 reduced their positions.
Institutional investors hold $40.69K worth of CLDI stock across 2 positions. The largest institutional holder is VANGUARD GROUP INC with $40.63K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CLDI, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CLDI positions.